Ind-Swift Laboratories Share Price

ABOUT Ind-Swift Laboratories

• Industry Major Drugs
• ISIN INE915B01019
• BSE Code 532305
• NSE Code INDSWFTLAB

Ind-Swift Laboratories Limited is an India-based company. The Company is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company’s products include APIs and Impurities. The Company offers reference standards and impurities for various APIs under British Pharmacopoeia (BP), European Pharmacopoeia (EP), British Pharmacopoeia (BP) and others. Its impurity portfolio is stocked with a range of standards for quick and reliable supply. The Company offers reference standards and impurities for over 25 APIs. All impurities are shipped with full documentation, including a Certificate of Analysis and MSDS. The research center, spread over the area of 40,000 square feet, is engaged in developing process technology for APIs in different therapeutic categories. Its products include Clarithromycin, Clarithromycin Coated Granules, Ezetimibe, Pazopanib HCl, Ranolazine, Aripiprazole, Letrozole, and Imatinib Mesylate, others.

MANAGEMENT

• Navrattan Munjal Executive Chairman of the Board, Managing Director
• Gagan Aggarwal Chief Financial Officer
• Vikas Narendra President - US Operations
• Rakesh Bahuguna Senior Vice President - QC
• Anurag Chaturvedi Senior Vice President - Marketing
• Varun Chhabra Senior Vice President - Marketing
• Ashok Prasad Senior Vice President - R&D
• Sandeep Singh Senior Vice President - Procurement
• Saranjai Tyagi Senior Vice President - QA
• Pardeep Verma Compliance Officer, Company Secretary, AVP - Corporate Affairs